Physician profile
Daniel Martin
NPI 1437414935
$3,961.27
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,176 · 2020: $134 · 2021: $343 · 2022: $399 · 2023: $852 · 2024: $56.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $612 · Food and Beverage: $241 · Gift: $56.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $611.63 |
| Food and Beverage | $241.03 |
| Gift | $56.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,714.06 | 2019-2023 | Da Vinci Surgical System |
| Davol INC. | $174.14 | 2020-2021 | |
| Organogenesis INC. | $153.85 | 2022-2023 | Puraply |
| Allergan, INC. | $146.79 | 2019-2022 | |
| Ethicon US, LLC | $143.43 | 2019-2021 | |
| Conmed Corporation | $113.40 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $91.66 | 2019 | |
| Axonics, INC. | $80.82 | 2023-2024 | Axonics |
| Baudax Bio INC. | $53.99 | 2021 | |
| Smith+Nephew, INC. | $52.48 | 2019-2022 | |
| Medtronic, INC. | $44.10 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.26 | 2021-2024 | Gattex |
| Pacira Pharmaceuticals Incorporated | $35.37 | 2020-2022 | |
| Merit Medical Systems INC | $32.80 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $31.63 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $26.37 | 2020-2021 | |
| Hologic INC | $16.33 | 2021 | |
| Reprise Biomedical, INC. | $13.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.